Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy.

ABSTRACT:

SUBMITTER: Galli M 

PROVIDER: S-EPMC6165822 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature